Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

IntroductionTo evaluate efficacy and secondary resectability in patients with locally advanced pancreatic cancer (LAPC) treated with neoadjuvant chemoradiotherapy (CRT).Patients and methodsA total of 215 patients with locally advanced pancreatic cancer were treated with chemoradiation at a single institution. Radiotherapy was delivered with a median dose of 52.2 Gy in single fractions of 1.8 Gy. Chemotherapy was applied concomitantly as gemcitabine (GEM) at a dose of 300 mg/m2 weekly, followed by adjuvant cycles of full-dose GEM (1000 mg/m2). After neoadjuvant CRT restaging was done to evaluate secondary resectability. Overall and disease-free survival were calculated and prognostic factors were estimated.ResultsAfter CRT a total of 26% of all patients with primary unresectable LAPC were chosen to undergo secondary resection. Tumour free resection margins could be achieved in 39.2% (R0-resection), R1-resections were seen in 41.2%, residual macroscopic tumour in 11.8% (R2) and in 7.8% resection were classified as Rx. Patients with complete resection after CRT showed a significantly increased median overall survival (OS) with 22.1 compared to 11.9 months in non-resected patients. Median OS and disease-free survival (DFS) of all patients were 12.3 and 8.1 months respectively. In most cases the first site of disease progression was systemic with hepatic (52%) and peritoneal (36%) metastases.DiscussionA high percentage of patients with locally advanced pancreatic cancer can undergo secondary resection after gemcitabine-based chemoradiation and has a relative long-term prognosis after complete resection.

[1]  C. Ko,et al.  National Failure to Operate on Early Stage Pancreatic Cancer , 2007, Annals of surgery.

[2]  H. Baumel,et al.  Exocrine Pancreatic Cancer , 1986, Springer Berlin Heidelberg.

[3]  H. Bartelink,et al.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Bond-Smith Giles,et al.  Only women with symptoms need to have their breast implants removed, says government , 2012 .

[5]  J. Cameron,et al.  One Thousand Consecutive Pancreaticoduodenectomies , 2006, Annals of surgery.

[6]  G. Grabenbauer,et al.  Adenocarcinoma of the esophagogastric junction: Neoadjuvant radiochemotherapy and radical surgery , 2011, Strahlentherapie und Onkologie.

[7]  Tibor Schuster,et al.  Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages , 2010, PLoS medicine.

[8]  H. Friess,et al.  Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. , 2003, Archives of surgery.

[9]  T. Brunner,et al.  The role of radiotherapy in multimodal treatment of pancreatic carcinoma , 2010, Radiation oncology.

[10]  D. Klimstra,et al.  Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. , 1996, Annals of surgery.

[11]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.

[12]  K. Lillemoe,et al.  Importance of hospital volume in the overall management of pancreatic cancer. , 1998, Annals of surgery.

[13]  H. Brambs,et al.  [S3-Guidelines "Exocrine pancreatic cancer" 2007]. , 2007 .

[14]  O. Stoeltzing,et al.  Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor , 2010, Langenbeck's Archives of Surgery.

[15]  H. Thompson.  Exocrine Pancreatic Cancer , 1988 .

[16]  C. Ko,et al.  Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. , 2008, Journal of the American College of Surgeons.

[17]  A. Scarpa,et al.  Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review , 2011, Langenbeck's Archives of Surgery.

[18]  J. Tielsch,et al.  The Effects of Regionalization on Cost and Outcome for One General High‐Risk Surgical Procedure , 1995, Annals of surgery.

[19]  S. Gallinger,et al.  Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. , 2004, Journal of the American College of Surgeons.

[20]  C. Ko,et al.  Prognostic Score Predicting Survival After Resection of Pancreatic Neuroendocrine Tumors: Analysis of 3851 Patients , 2008, Annals of surgery.

[21]  G. La Torre,et al.  A Systematic Review of Resectability and Survival After Concurrent Chemoradiation in Primarily Unresectable Pancreatic Cancer , 2009, Annals of Surgical Oncology.

[22]  J. Debus,et al.  Neoadjuvant Capecitabine Combined with Standard Radiotherapy in Patients with Locally Advanced Rectal Cancer , 2008, Strahlentherapie und Onkologie.

[23]  B. Topal,et al.  Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[24]  V. Heinemann,et al.  Gemcitabine: metabolism, mechanisms of action, and self-potentiation. , 1995, Seminars in oncology.

[25]  R. Weber,et al.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.

[26]  C. Ko,et al.  Multimodality therapy for pancreatic cancer in the U.S. , 2007, Cancer.

[27]  C. Anderson,et al.  Radiation Oncology , 2001, Springer International Publishing.

[28]  P. Imperato,et al.  The Effects of Regionalization on Clinical Outcomes for a High Risk Surgical Procedure: A Study of the Whipple Procedure in New York State , 1996, American journal of medical quality : the official journal of the American College of Medical Quality.

[29]  Nils Lehmann,et al.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  T. Lawrence,et al.  Gemcitabine-mediated radiosensitization. , 1997, Seminars in oncology.

[31]  W. Hohenberger,et al.  Downstaging of Pancreatic Carcinoma after Neoadjuvant Chemoradiation , 2009, Strahlentherapie und Onkologie.

[32]  H. Eich,et al.  Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer , 2011, Strahlentherapie und Onkologie.

[33]  D. Winchester,et al.  Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.

[34]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[35]  A. Piccoli,et al.  Survival after resection for ductal adenocarcinoma of the pancreas , 1996, The British journal of surgery.

[36]  S. Saglam,et al.  Long-term survival after curative resection for pancreatic ductal adenocarcinoma , 2004 .

[37]  E. Nakakura,et al.  Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology. , 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

[38]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[39]  J. Feinglass,et al.  Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  P. Möller,et al.  S3-Leitlinie zum exokrinen Pankreaskarzinom , 2013, Zeitschrift für Gastroenterologie.

[41]  J. Neoptolemos,et al.  Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study , 1995, The British journal of surgery.